Trinity Biotech plc

NASDAQ:TRIB

Medical - Diagnostics & Research

Healthcare
$5.83 -5.73%

-$0.51 today

Market cap
$117.96M
Beta
1.00
P/E (TTM)
-0.1
EPS (TTM)
-$60.27
52W Low $8.00High $103.20

Volume 0.00M

Average 1.34M

TRIB Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Trinity Biotech plcNASDAQ: TRIB

Capital Expenditures · Q4 FY2025 · quarter ended Dec 2025

Capital expenditures turns positive

Q4 FY2025 capital expenditures was $11.14K, compared with -$2.74M a year earlier. Trailing-twelve-month capital expenditures was -$88.26K. Over 3 fiscal years it compounded at +1.4% a year.

Context

  • Capital expenditures amounted to 14.2% of revenue in FY2025, down 2.1 pp from a year earlier.
  • Capital expenditures grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly capital expenditures holds near $11.14K or moves back toward the trailing-twelve-month quarterly average of -$22.07K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
$11.14K+296.7% QoQ
Last fiscal yearDec 2025
-$6.22M-38.2% YoY
LTMDec 2025
-$88.26K-99.1% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+100.4%——
1 year-38.2%——
3-year CAGR+1.4%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(6.22M) USD
Year-over-year change
+38.2%

Capital Expenditures vs competitors

How TRIB compares with its peers on the latest reported figures

No competitor Capital Expenditures figures are available to compare.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income875K(41.01M)(24.02M)(31.79M)(37.38M)
Depreciation & Amortization2.74M2.33M1.78M1.87M2.68M
Deferred Income Tax(167K)(192K)(59K)486K199K
Stock-Based Compensation1.1M1.76M2.07M1.32M324K
Change in Working Capital(172K)(1.66M)(2.69M)6.19M7.03M
Accounts Receivables6.24M(966K)1.05M(2.37M)4.92M
Inventory(4.41M)(877K)(971K)(1.74M)90K
Accounts Payables(7.59M)181K(2.77M)8.19M0
Other Working Capital5.59M7.57M(478K)10.3M2.02M
Other Non-Cash Items8.86M37.85M11.37M17.74M21.21M
Operating Cash Flow13.24M(921K)(11.56M)(4.19M)(5.93M)
Capital Expenditures(8.69M)(5.98M)(803K)(10.06M)(6.22M)
Acquisitions (Net)0028.16M(12.9M)0
Purchases of Investments00(700K)00
Sales of Investments00000
Other Investing Activities(6.88M)(4.88M)(1.9M)(9.66M)(6.14M)
Investing Cash Flow(8.69M)(5.98M)24.76M(22.97M)(6.22M)
Debt Repayment(2.94M)(27.04M)(7.37M)27.67M11.81M
Common Stock Issued025.34M07.39M547K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(3.08M)(10.61M)(8.67M)(6.25M)(308K)
Financing Cash Flow(6.02M)(12.32M)(16.04M)28.81M12.05M
Effect of Forex Changes55K(112K)(44K)(175K)71K
Net Change in Cash(1.42M)(19.33M)(2.89M)1.48M(29K)
Free Cash Flow4.55M(6.9M)(12.36M)(14.26M)(12.15M)

Trinity Biotech plc

NASDAQ:TRIB

Intrinsic Alpha fair value

Locked

Current Price

$5.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.